Proceeds Purposes The new round of funding will be used to continue expanding our clinical data platform, enriching our analytics services and building out connectivity to additional data sources. We also will broaden and enhance our product offerings for physicians and consumers, and develop new patient engagement services.
M&A Terms
Venture Investor Merck Global Health Innovation Fund